|
|
double strand break repair
|
GO:0006302 |
101 |
1.000
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.999
|
Human |
|
|
dna repair
|
GO:0006281 |
198 |
0.999
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.999
|
Human |
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.989
|
|
|
|
dna recombination
|
GO:0006310 |
77 |
0.980
|
|
|
|
dna double strand break processing
|
GO:0000729 |
10 |
0.978
|
|
|
|
regulation of protein autophosphorylation
|
GO:0031952 |
15 |
0.956
|
|
|
|
v d j recombination
|
GO:0033151 |
3 |
0.954
|
|
|
|
nucleotide excision repair
|
GO:0006289 |
31 |
0.951
|
|
|
|
telomere capping
|
GO:0016233 |
5 |
0.947
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
3 |
0.942
|
|
|
|
base excision repair
|
GO:0006284 |
21 |
0.928
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.915
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.891
|
Human |
|
|
g2 dna damage checkpoint
|
GO:0031572 |
26 |
0.884
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.868
|
Human |
|
|
dna damage induced protein phosphorylation
|
GO:0006975 |
5 |
0.860
|
|
|
|
regulation of dna repair
|
GO:0006282 |
47 |
0.845
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
9 |
0.843
|
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
50 |
0.837
|
|
|
|
regulation of chromosome segregation
|
GO:0051983 |
44 |
0.836
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.825
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.825
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.816
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.811
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.806
|
Human |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.781
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.780
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
4 |
0.770
|
|
|
|
double strand break repair via single strand annealing
|
GO:0045002 |
4 |
0.763
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.758
|
|
|
|
positive regulation of immunoglobulin mediated immune response
|
GO:0002891 |
4 |
0.755
|
|
|
|
isotype switching
|
GO:0045190 |
3 |
0.729
|
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
10 |
0.721
|
|
|
|
dna geometric change
|
GO:0032392 |
32 |
0.716
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.680
|
|
|
|
non recombinational repair
|
GO:0000726 |
14 |
0.680
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.667
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.667
|
|
|
|
histone ubiquitination
|
GO:0016574 |
31 |
0.661
|
|
|
|
regulation of sister chromatid segregation
|
GO:0033045 |
27 |
0.646
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.644
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.640
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.633
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.617
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.609
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.600
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.586
|
|
|
|
regulation of double strand break repair
|
GO:2000779 |
22 |
0.584
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.582
|
Human |
|
|
somatic recombination of immunoglobulin genes involved in immune response
|
GO:0002204 |
3 |
0.543
|
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
4 |
0.542
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.535
|
Human |
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.520
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.508
|
|
|
|
dna catabolic process exonucleolytic
|
GO:0000738 |
17 |
0.503
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.477
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.459
|
Human |
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.457
|
|
|
|
dna duplex unwinding
|
GO:0032508 |
30 |
0.455
|
|
|
|
nuclear division
|
GO:0000280 |
128 |
0.422
|
|
|
|
negative regulation of metaphase anaphase transition of cell cycle
|
GO:1902100 |
17 |
0.421
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.420
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
44 |
0.418
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
1 |
0.414
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.400
|
|
|
|
recombinational repair
|
GO:0000725 |
50 |
0.390
|
|
|
|
positive regulation of dna repair
|
GO:0045739 |
25 |
0.387
|
|
|
|
replication fork processing
|
GO:0031297 |
13 |
0.386
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.377
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.375
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.366
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
6 |
0.362
|
|
|
|
sister chromatid cohesion
|
GO:0007062 |
24 |
0.361
|
|
|
|
positive regulation of response to dna damage stimulus
|
GO:2001022 |
43 |
0.361
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.346
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
13 |
0.333
|
|
|
|
adaptive immune response
|
GO:0002250 |
49 |
0.329
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.325
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
30 |
0.322
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.321
|
Human |
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.319
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.317
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
8 |
0.315
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.312
|
|
|
|
positive regulation of isotype switching
|
GO:0045830 |
2 |
0.305
|
|
|
|
positive regulation of b cell mediated immunity
|
GO:0002714 |
4 |
0.304
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.297
|
|
|
|
septum secundum development
|
GO:0003285 |
2 |
0.280
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
15 |
0.275
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
48 |
0.274
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.273
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.264
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.256
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.247
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.244
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.240
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.236
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.235
|
|
|
|
negative regulation of megakaryocyte differentiation
|
GO:0045653 |
16 |
0.234
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.228
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
54 |
0.223
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.217
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.211
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.197
|
Human |
|
|
regulation of mitotic metaphase anaphase transition
|
GO:0030071 |
26 |
0.187
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.185
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.180
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.174
|
|
|
|
dna synthesis involved in dna repair
|
GO:0000731 |
6 |
0.173
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
7 |
0.172
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.167
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.164
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.163
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.162
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.162
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.161
|
|
|
|
telomere maintenance via telomere lengthening
|
GO:0010833 |
9 |
0.160
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.158
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.150
|
|
|
|
response to gamma radiation
|
GO:0010332 |
14 |
0.148
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.147
|
Human |
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.146
|
|
|
|
histone h2a phosphorylation
|
GO:1990164 |
3 |
0.145
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
37 |
0.141
|
|
|
|
positive regulation of isotype switching to iga isotypes
|
GO:0048298 |
2 |
0.140
|
|
|
|
regulation of mitosis
|
GO:0007088 |
63 |
0.137
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
20 |
0.137
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
30 |
0.134
|
|
|
|
reciprocal dna recombination
|
GO:0035825 |
4 |
0.130
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.130
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.129
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.124
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.123
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.119
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.116
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
59 |
0.113
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.112
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.109
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.106
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
40 |
0.104
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.102
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.101
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.101
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.101
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.099
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.098
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
6 |
0.098
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.095
|
|
|
|
negative regulation of dna endoreduplication
|
GO:0032876 |
5 |
0.094
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
7 |
0.093
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.093
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
4 |
0.092
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.091
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.090
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.090
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.090
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.089
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.088
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.087
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
13 |
0.086
|
|
|
|
protein deubiquitination
|
GO:0016579 |
79 |
0.084
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.084
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.084
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.082
|
|
|
|
positive regulation of dna replication
|
GO:0045740 |
35 |
0.081
|
|
|
|
septum primum development
|
GO:0003284 |
1 |
0.079
|
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
38 |
0.078
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
1 |
0.077
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.077
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.076
|
|
|
|
immunoglobulin production involved in immunoglobulin mediated immune response
|
GO:0002381 |
5 |
0.074
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
48 |
0.074
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.073
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.073
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.072
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.072
|
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
53 |
0.072
|
|
|
|
positive regulation of dna damage response signal transduction by p53 class mediator
|
GO:0043517 |
8 |
0.072
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.071
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
24 |
0.070
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.069
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.069
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.069
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.069
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.068
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.068
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.068
|
|
|
|
regulation of dna recombination
|
GO:0000018 |
23 |
0.068
|
|
|
|
regulation of mitotic sister chromatid separation
|
GO:0010965 |
27 |
0.067
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.066
|
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
9 |
0.066
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.066
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.065
|
|
|
|
protein k48 linked ubiquitination
|
GO:0070936 |
38 |
0.065
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.065
|
|
|
|
negative regulation of sister chromatid segregation
|
GO:0033046 |
17 |
0.064
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.064
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.062
|
|
|
|
gene silencing
|
GO:0016458 |
49 |
0.061
|
|
|
|
mismatch repair
|
GO:0006298 |
15 |
0.059
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.058
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.058
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.056
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.055
|
|
|
|
neuromuscular process
|
GO:0050905 |
15 |
0.054
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.053
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.052
|
|
|
|
establishment of nucleus localization
|
GO:0040023 |
1 |
0.052
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.051
|
Human |
|
|
negative regulation of histone h3 k9 methylation
|
GO:0051573 |
3 |
0.051
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.051
|
|
|
|
phosphatidylinositol 3 phosphate biosynthetic process
|
GO:0036092 |
3 |
0.050
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.050
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.049
|
|
|
|
histone h2a k63 linked ubiquitination
|
GO:0070535 |
5 |
0.049
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.049
|
|
|
|
atrial septum secundum morphogenesis
|
GO:0003290 |
1 |
0.049
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.049
|
|
|
|
mitotic spindle checkpoint
|
GO:0071174 |
18 |
0.049
|
|
|
|
spindle checkpoint
|
GO:0031577 |
26 |
0.048
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.048
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.048
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
8 |
0.047
|
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
7 |
0.047
|
|
|
|
rna dependent dna replication
|
GO:0006278 |
16 |
0.047
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.046
|
|
|
|
nucleosome organization
|
GO:0034728 |
66 |
0.046
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
7 |
0.046
|
|
|
|
chromosome condensation
|
GO:0030261 |
15 |
0.046
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.045
|
|
|
|
mitotic recombination
|
GO:0006312 |
8 |
0.044
|
|
|
|
negative regulation of mitosis
|
GO:0045839 |
24 |
0.043
|
|
|
|
negative regulation of b cell proliferation
|
GO:0030889 |
5 |
0.043
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.043
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.043
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.042
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.042
|
|
|
|
dna damage response signal transduction resulting in transcription
|
GO:0042772 |
12 |
0.042
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.042
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.042
|
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
14 |
0.042
|
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.041
|
Human |
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.041
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
81 |
0.041
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.040
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.040
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.040
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.039
|
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.039
|
|
|
|
histone h3 k36 methylation
|
GO:0010452 |
5 |
0.039
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.039
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.038
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.038
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.038
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.038
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.037
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.037
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.037
|
|
|
|
centrosome organization
|
GO:0051297 |
58 |
0.036
|
|
|
|
positive regulation of dna recombination
|
GO:0045911 |
3 |
0.036
|
|
|
|
nuclear migration
|
GO:0007097 |
1 |
0.036
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.036
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.035
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.035
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.034
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.034
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
61 |
0.034
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
83 |
0.034
|
|
|
|
chromosome separation
|
GO:0051304 |
23 |
0.034
|
|
|
|
positive regulation of transcription factor import into nucleus
|
GO:0042993 |
25 |
0.034
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
91 |
0.033
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.032
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
25 |
0.032
|
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
27 |
0.032
|
Human |
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
10 |
0.032
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.031
|
Human |
|
|
histone h4 k20 methylation
|
GO:0034770 |
1 |
0.031
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
1 |
0.031
|
|
|
|
regulation of isotype switching
|
GO:0045191 |
2 |
0.030
|
|
|
|
negative regulation of mitotic sister chromatid segregation
|
GO:0033048 |
17 |
0.030
|
|
|
|
b cell activation
|
GO:0042113 |
33 |
0.030
|
|
|
|
regulation of dna endoreduplication
|
GO:0032875 |
5 |
0.030
|
|
|
|
nucleus localization
|
GO:0051647 |
1 |
0.029
|
|
|
|
mrna processing
|
GO:0006397 |
133 |
0.029
|
|
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
35 |
0.029
|
|
|
|
metaphase anaphase transition of cell cycle
|
GO:0044784 |
21 |
0.029
|
|
|
|
protein k63 linked ubiquitination
|
GO:0070534 |
31 |
0.029
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.028
|
|
|
|
telomere maintenance
|
GO:0000723 |
32 |
0.028
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.028
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.028
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.028
|
|
|
|
regulation of dna dependent dna replication
|
GO:0090329 |
19 |
0.028
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.027
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.027
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
29 |
0.027
|
|
|
|
interstrand cross link repair
|
GO:0036297 |
3 |
0.027
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.027
|
|
|
|
dna strand elongation involved in dna replication
|
GO:0006271 |
3 |
0.026
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
37 |
0.026
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.026
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.026
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.026
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.026
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.026
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.026
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
48 |
0.026
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.025
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.025
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.025
|
|
|
|
dna replication independent nucleosome organization
|
GO:0034724 |
27 |
0.025
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
40 |
0.025
|
|
|
|
isotype switching to iga isotypes
|
GO:0048290 |
2 |
0.024
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.024
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.024
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.024
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
16 |
0.023
|
|
|
|
telomere maintenance via recombination
|
GO:0000722 |
4 |
0.023
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.023
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.023
|
|
|
|
positive regulation of histone h3 k4 methylation
|
GO:0051571 |
8 |
0.023
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.023
|
|
|
|
microtubule anchoring
|
GO:0034453 |
24 |
0.023
|
|
|
|
spindle assembly checkpoint
|
GO:0071173 |
17 |
0.023
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
10 |
0.023
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.023
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.023
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.022
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.022
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.022
|
|
|
|
chromatin silencing
|
GO:0006342 |
12 |
0.022
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.022
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.022
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.022
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.022
|
|
|
|
negative regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034244 |
4 |
0.022
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.021
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.021
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
33 |
0.021
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.021
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.021
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.021
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
92 |
0.021
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.021
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.021
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.021
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.020
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.020
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.020
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.020
|
|
|
|
oocyte maturation
|
GO:0001556 |
1 |
0.020
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.020
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.020
|
|
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.020
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
0.020
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
21 |
0.020
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.020
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.019
|
Human |
|
|
response to purine containing compound
|
GO:0014074 |
40 |
0.019
|
|
|
|
dna strand elongation
|
GO:0022616 |
5 |
0.019
|
|
|
|
negative regulation of mitotic metaphase anaphase transition
|
GO:0045841 |
17 |
0.019
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
9 |
0.019
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.019
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.019
|
|
|
|
negative regulation of g2 m transition of mitotic cell cycle
|
GO:0010972 |
9 |
0.019
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.019
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.019
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.019
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.019
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
18 |
0.019
|
|
|
|
specification of axis polarity
|
GO:0065001 |
1 |
0.018
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
59 |
0.018
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.018
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
76 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.018
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.018
|
|
|
|
mitotic spindle assembly checkpoint
|
GO:0007094 |
14 |
0.018
|
|
|
|
regulation of telomere maintenance
|
GO:0032204 |
13 |
0.018
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
18 |
0.017
|
|
|
|
single strand break repair
|
GO:0000012 |
6 |
0.017
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.017
|
|
|
|
male meiosis
|
GO:0007140 |
1 |
0.017
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.017
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.017
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.017
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.017
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.017
|
|
|
|
regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034243 |
13 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.017
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.017
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.016
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.016
|
|
|
|
peptide metabolic process
|
GO:0006518 |
51 |
0.016
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.016
|
|
|
|
regulation of signal transduction by p53 class mediator
|
GO:1901796 |
26 |
0.016
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
50 |
0.016
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.016
|
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
39 |
0.016
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.016
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.015
|
|
|
|
telomere maintenance via telomerase
|
GO:0007004 |
8 |
0.015
|
|
|
|
neuron remodeling
|
GO:0016322 |
2 |
0.015
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
51 |
0.015
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.015
|
|
|
|
adipose tissue development
|
GO:0060612 |
2 |
0.015
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
62 |
0.015
|
|
|
|
protein alkylation
|
GO:0008213 |
74 |
0.015
|
Human |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.015
|
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.015
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.015
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.015
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.015
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
42 |
0.015
|
|
|
|
head development
|
GO:0060322 |
108 |
0.015
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.015
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.014
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.014
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
23 |
0.014
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.014
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.014
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.014
|
|
|
|
protein k63 linked deubiquitination
|
GO:0070536 |
21 |
0.014
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
65 |
0.014
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.014
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.014
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.014
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.013
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.013
|
|
|
|
male gonad development
|
GO:0008584 |
23 |
0.013
|
|
|
|
telomere organization
|
GO:0032200 |
33 |
0.013
|
|
|
|
regulation of oxidative stress induced cell death
|
GO:1903201 |
24 |
0.013
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.013
|
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
20 |
0.013
|
|
|
|
positive regulation of telomere maintenance
|
GO:0032206 |
4 |
0.013
|
|
|
|
negative regulation of mitotic sister chromatid separation
|
GO:2000816 |
17 |
0.013
|
|
|
|
detection of stimulus
|
GO:0051606 |
85 |
0.013
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.013
|
|
|
|
protein k11 linked ubiquitination
|
GO:0070979 |
24 |
0.013
|
|
|
|
vascular smooth muscle cell differentiation
|
GO:0035886 |
3 |
0.013
|
|
|
|
maintenance of dna repeat elements
|
GO:0043570 |
4 |
0.013
|
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
23 |
0.012
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
54 |
0.012
|
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
10 |
0.012
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.012
|
|
|
|
response to alkaloid
|
GO:0043279 |
20 |
0.012
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.012
|
|
|
|
negative regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032435 |
30 |
0.012
|
|
|
|
dna unwinding involved in dna replication
|
GO:0006268 |
2 |
0.012
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.012
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
74 |
0.012
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.012
|
|
|
|
mitotic nuclear envelope reassembly
|
GO:0007084 |
3 |
0.012
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.012
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.012
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.012
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.012
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.012
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
10 |
0.011
|
|
|
|
negative regulation of hematopoietic progenitor cell differentiation
|
GO:1901533 |
18 |
0.011
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
38 |
0.011
|
|